NCT04777175

A Retrospective Study: Evaluation of the Efficacy of Immunotherapy With Rare Mutations in Non-small Cell Lung Cancer

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 186 (estimated)
• Sponsor: Yongchang Zhang · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

In advanced non-small cell lung cancer, there will be some rare mutations, such as ALK, KRAS, etc. The efficacy of these immunotherapies on these different rare mutations has not been reported. Therefore, we conducted this retrospective clinical study to explore the efficacy of immunotherapy for different rare mutations.

Conditions

• Non Small Cell Lung Cancer

Interventions

Type	Name	Description
DRUG	immunity therapy	The patient receives immunotherapy

Timeline

• Start date: 2023-01-01
• Primary completion: 2025-01-01
• Completion: 2025-01-12
• First posted: 2021-03-02
• Last updated: 2024-09-19

Locations

2 sites across 1 country: China